Seohomedico(Microport)
Within two decades, MicroPort has transformed itself from a market follower, into a global leader in the field of Percutaneous Coronary Intervention (PCI). Its proprietary Firehawk targeted eluting stent system, with proven clinical evidence in terms of safety and efficacy, has become a leading stent, setting industry standards for a new generation of global cardiac stents.